Nouveau Biosciences

Nouveau BioSciences is a biotechnology company pioneering novel drug development technology that leverages high-throughput chemical and genomic screening to create targeted nanomedicines for cancer treatment. The company has entered into multiple licensing agreements with the University of Virginia to expand its pipeline of innovative nanomedicines.